(Q47567895)

4 February 2018

http://europepmc.org/abstract/MED/28975625

title

Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/28975625

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Lokesh Dalasanur Nagaprashantha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ramesh Adhikari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jyotsana Singhal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shireen Chikara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sanjay Awasthi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

David Horne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

4 October 2017

1 reference

4 February 2018

http://europepmc.org/abstract/MED/28975625

published in

International Journal of Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

658-670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

cites work

Cancer statistics, 2010

1 reference

Temporal trends in breast cancer mortality by state and race

21 January 2018

1 reference

Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.

21 January 2018

1 reference

21 January 2018

Cancer Statistics, 2017.

1 reference

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

Ten genes for inherited breast cancer.

21 January 2018

1 reference

Breast cancer susceptibility: current knowledge and implications for genetic counselling

21 January 2018

1 reference

Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.

21 January 2018

1 reference

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

21 January 2018

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

DNA damage sensing by the ATM and ATR kinases.

21 January 2018

1 reference

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function

21 January 2018

1 reference

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

21 January 2018

1 reference

Structural basis for recruitment of BRCA2 by PALB2

21 January 2018

1 reference

Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.

21 January 2018

1 reference

Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study

21 January 2018

1 reference

Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K

21 January 2018

1 reference

Estrogen and the risk of breast cancer

21 January 2018

1 reference

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

21 January 2018

1 reference

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

Control of mammary stem cell function by steroid hormone signalling.

21 January 2018

1 reference

Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway

21 January 2018

1 reference

Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair

21 January 2018

1 reference

Estrogen signaling: a subtle balance between ER alpha and ER beta

21 January 2018

1 reference

Distinct expression patterns of ER alpha and ER beta in normal human mammary gland

21 January 2018

1 reference

Steroid hormone antagonists. Summary and future challenges.

21 January 2018

1 reference

Estrogen signaling multiple pathways to impact gene transcription

21 January 2018

1 reference

Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen

21 January 2018

1 reference

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner

21 January 2018

1 reference

Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells

21 January 2018

1 reference

Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.

21 January 2018

1 reference

17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells

21 January 2018

1 reference

Breast cancer: a candidate gene approach across the estrogen metabolic pathway

21 January 2018

1 reference

Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction

21 January 2018

1 reference

Cytochrome P450 1B1-Mediated Estrogen Metabolism Results in Estrogen-Deoxyribonucleoside Adduct Formation

21 January 2018

1 reference

Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression

21 January 2018

1 reference

Active smoking and breast cancer risk: original cohort data and meta-analysis

21 January 2018

1 reference

Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells

21 January 2018

1 reference

Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells

21 January 2018

1 reference

Dose-dependent effect of alcohol on insulin-like growth factor systems in male rats

21 January 2018

1 reference

Alcohol and Breast Cancer in Women

21 January 2018

1 reference

Stimulation of cell invasion and migration by alcohol in breast cancer cells.

21 January 2018

1 reference

The inflammation highway: metabolism accelerates inflammatory traffic in obesity

21 January 2018

1 reference

High body mass index and cancer risk-a Mendelian randomisation study

21 January 2018

1 reference

High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring

21 January 2018

1 reference

Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression

21 January 2018

1 reference

Leptin-Induced JAK/STAT Signaling and Cancer Growth

21 January 2018

1 reference

Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers

21 January 2018

1 reference

Angiogenesis, adipokines and breast cancer

21 January 2018

1 reference

Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells

21 January 2018

1 reference

Aromatase, breast cancer and obesity: a complex interaction

21 January 2018

1 reference

Leptin and leptin receptor expression in breast cancer

21 January 2018

1 reference

Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.

21 January 2018

1 reference

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.

21 January 2018

1 reference

HER2 induces expression of leptin in human breast epithelial cells

21 January 2018

1 reference

Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells

21 January 2018

1 reference

Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines

21 January 2018

1 reference

Dietary fat intake and development of specific breast cancer subtypes

21 January 2018

1 reference

Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets

21 January 2018

1 reference

Natural Products for Chemoprevention of Breast Cancer

21 January 2018

1 reference

Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices

21 January 2018

1 reference

Citrus fruit intake and breast cancer risk: a quantitative systematic review

21 January 2018

1 reference

Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21.

21 January 2018

1 reference

Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells

21 January 2018

1 reference

Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice

21 January 2018

1 reference

Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.

21 January 2018

1 reference

Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells

21 January 2018

1 reference

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9.

21 January 2018

1 reference

Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation.

21 January 2018

1 reference

Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.

21 January 2018

1 reference

Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop

21 January 2018

1 reference

3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation

21 January 2018

1 reference

Estrogen receptor alpha as a target for indole-3-carbinol

21 January 2018

1 reference

Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies

21 January 2018

1 reference

Cucurbitacins and cucurbitane glycosides: structures and biological activities

21 January 2018

1 reference

Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression

21 January 2018

1 reference

Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells

21 January 2018

1 reference

DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis

21 January 2018

1 reference

The Dachshund gene in development and hormone-responsive tumorigenesis

21 January 2018

1 reference

Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.

21 January 2018

1 reference

PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growth

21 January 2018

1 reference

Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models

21 January 2018

1 reference

The effect of curcumin on breast cancer cells

21 January 2018

1 reference

Chemopreventive and chemotherapeutic potential of curcumin in breast cancer

21 January 2018

1 reference

Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation

21 January 2018

1 reference

Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables

21 January 2018

1 reference

EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression

21 January 2018

1 reference

Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process

21 January 2018

1 reference

Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans.

21 January 2018

1 reference

Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells

21 January 2018

1 reference

Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells

21 January 2018

1 reference

Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.

21 January 2018

1 reference

Antiproliferative activity of daidzein and genistein may be related to ERα/c-erbB-2 expression in human breast cancer cells

21 January 2018

1 reference

Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis

21 January 2018

1 reference

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

21 January 2018

1 reference

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

21 January 2018

1 reference

Biological subtypes of breast cancer: Prognostic and therapeutic implications

21 January 2018

1 reference

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

21 January 2018

1 reference

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

21 January 2018

1 reference

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

21 January 2018

1 reference

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment.

21 January 2018

1 reference

Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.

21 January 2018

1 reference

Embryonic transcription factor SOX9 drives breast cancer endocrine resistance

21 January 2018

1 reference

NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.

21 January 2018

1 reference

Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms

21 January 2018

1 reference

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

21 January 2018

1 reference

Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer

21 January 2018

1 reference

Topoisomerase levels determine chemotherapy responsein vitroandin vivo

21 January 2018

1 reference

Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy.

21 January 2018

1 reference

Anthracycline Chemotherapy and Cardiotoxicity.

21 January 2018

1 reference

Cyclophosphamide toxicity. Characterising and avoiding the problem

21 January 2018

1 reference

Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers

21 January 2018

1 reference

Presentation and management of docetaxel-related adverse effects in patients with breast cancer

21 January 2018

1 reference

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies

21 January 2018

1 reference

Chrysin, Abundant in Morinda citrifolia Fruit Water-EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells

21 January 2018

1 reference

Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death.

21 January 2018

1 reference

Extending Adjuvant Aromatase-Inhibitor Therapy to 10 Years.

21 January 2018

1 reference

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

21 January 2018

1 reference

Mechanism of Off-Target Interactions and Toxicity of Tamoxifen and Its Metabolites

21 January 2018

1 reference

Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression.

21 January 2018

1 reference

Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy

21 January 2018

1 reference

Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats

21 January 2018

1 reference

Adverse effects of bisphosphonates: implications for osteoporosis management

21 January 2018

1 reference

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

21 January 2018

1 reference

The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer

21 January 2018

1 reference

Coadministrating luteolin minimizes the side effects of the aromatase inhibitor letrozole.

21 January 2018

1 reference

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

21 January 2018

1 reference

Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells

21 January 2018

1 reference

Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice

21 January 2018

1 reference

Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.

21 January 2018

1 reference

Association between global DNA hypomethylation in leukocytes and risk of breast cancer

21 January 2018

1 reference

Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity

21 January 2018

1 reference

Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.

21 January 2018

1 reference

Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer

21 January 2018

1 reference

Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

21 January 2018

1 reference

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

21 January 2018

1 reference

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

21 January 2018

1 reference

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.

21 January 2018

1 reference

Gene Expression Profiling of Breast Cancer Brain Metastasis

21 January 2018

1 reference

21 January 2018

1 reference

2'-Hydroxyflavanone: A novel strategy for targeting breast cancer

21 January 2018

1 reference

Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy

21 January 2018

1 reference

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

21 January 2018

1 reference

A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.

21 January 2018

1 reference

Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha

21 January 2018

1 reference

Apigenin suppresses cancer cell growth through ERbeta

21 January 2018

1 reference

Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element

21 January 2018

1 reference

Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF)

21 January 2018

1 reference

Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates

21 January 2018

1 reference

Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.31085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference